Outcome of combined bevacizumab and irinotecan for patients with progressive brain metastases from non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Brosnan, Evelyn M.
Fadul, Camilo E.
Dragnev, Konstantin H.
Davis, Melissa C.
Shah, Khushboo A.
Eskey, Clifford J.
机构：
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[2] Dartmouth Hitchcock Medcl Ctr, Lebanon, NH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19059
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Radiographic Response of Brain Metastases in Patients With Non-small Cell Lung Cancer Receiving Bevacizumab
    Rhodes, S. B.
    Ewend, M. G.
    Morris, D. E.
    Chu, H.
    Socinski, M. A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S537 - S537
  • [12] The impact of age and performance status on outcome of brain metastases in non-small cell lung cancer (NSCLC)
    Larbi, E.
    Middleton, G.
    Partridge-James, T.
    Quirin, S.
    Hardacre, V.
    Broadbanks, C.
    Dennis, L.
    Russell, S.
    Davies, C.
    Illsley, M.
    Ezhil, V.
    LUNG CANCER, 2012, 75 : S52 - S52
  • [13] Brain metastases manifestaion of advanced non-small cell lung cancer (NSCLC)
    Koyi, H.
    Branden, E.
    Daham, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [14] Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer
    Kevin C. De Braganca
    Yelena Y. Janjigian
    Christopher G. Azzoli
    Mark G. Kris
    Maria C. Pietanza
    Craig P. Nolan
    Antonio M. Omuro
    Andrei I. Holodny
    Andrew B. Lassman
    Journal of Neuro-Oncology, 2010, 100 : 443 - 447
  • [15] Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer
    De Braganca, Kevin C.
    Janjigian, Yelena Y.
    Azzoli, Christopher G.
    Kris, Mark G.
    Pietanza, Maria C.
    Nolan, Craig P.
    Omuro, Antonio M.
    Holodny, Andrei I.
    Lassman, Andrew B.
    JOURNAL OF NEURO-ONCOLOGY, 2010, 100 (03) : 443 - 447
  • [16] The impact of surgery on the outcome of patients with non-small cell lung cancer (NSCLC) and brain metastasis
    Dediu, Mircea
    Horvat, Teodor
    Tarlea, Alin
    Median, Dragos
    Alexandru, Aurelia
    Miron, Geanina
    ANNALS OF ONCOLOGY, 2004, 15 : 171 - 171
  • [17] Acceptable safety of bevacizumab therapy in patients with brain metastases due to non-small cell lung cancer
    Akerley, W. L.
    Langer, C. J.
    Oh, Y.
    Strickland, D. K.
    Royer, S. Joo
    Xia, Q.
    Mu, Y.
    Huang, J.
    Socinski, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [18] Retrospective study on bevacizumab in the treatment of non-small cell lung cancer with brain metastases
    Wang, Zhen
    Yang, Jin-Ji
    Tu, Hai-Yan
    Yan, Hong-Hong
    Wu, Yi-Long
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (02) : 267 - 273
  • [19] Retrospective study on bevacizumab in the treatment of non-small cell lung cancer with brain metastases
    Zhen Wang
    Jin-Ji Yang
    Hai-Yan Tu
    Hong-Hong Yan
    Yi-Long Wu
    International Journal of Clinical Oncology, 2020, 25 : 267 - 273
  • [20] Brain metastases in patients with stage N2 non-small cell lung cancer (NSCLC)
    Ansel, S.
    McCully, E.
    Lowrie, C.
    Banfill, K.
    McLoone, P. M.
    Mohammed, N.
    LUNG CANCER, 2018, 115 : S19 - S20
12345